Dr. Lichtenfeld is an experienced medical oncologist and independent consultant with an extensive background in cancer care, cancer research, healthcare policy, and physician payment. He is a member of the CancerCare board of directors, and an advisor to several early-stage patient- and cancer-focused companies, including Trialjectory and OneHealth. Dr. Lichtenfeld was previously the Chief Medical and Scientific Officer, and Deputy Chief Medical Officer for the American Cancer Society. He received a bachelor’s degree in sociology from the University of Pennsylvania, a medical degree from Hahnemann Medical College (now Drexel University College of Medicine) and medical training at Temple University, Johns Hopkins and the National Cancer Institute.